EHAB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Enhabit Inc. (EHAB) is not a strong buy at the moment for a beginner investor with a long-term focus. The stock is trading near its acquisition price of $13.80, which limits upside potential. While technical indicators show bullish momentum, the overbought RSI and lack of significant growth in financial performance suggest limited room for further gains. Additionally, the ongoing investigations into the acquisition could create uncertainties. A hold position is recommended until more clarity emerges or a better entry point is available.
The stock shows bullish momentum with MACD positively expanding and moving averages in a bullish alignment (SMA_5 > SMA_20 > SMA_200). However, the RSI is at 89.385, indicating an overbought condition. The stock is trading near its resistance level of R1: 13.278 and approaching the acquisition price of $13.80, limiting upside potential.
Acquisition by Kinderhook Industries at $13.80 per share in cash, providing a floor for the stock price.
Improved reimbursement visibility and operational initiatives as noted by analysts.
Bullish technical indicators, including MACD and moving averages.
Investigations into the acquisition by multiple law firms, creating potential legal and regulatory uncertainties.
Overbought RSI, suggesting limited short-term upside.
Declining net income and EPS in the latest financial quarter, indicating financial challenges.
In Q3 2025, revenue increased by 3.94% YoY to $263.6M, but net income dropped by -110.07% YoY to $11.1M, and EPS fell by -110.00% YoY to $0.22. Gross margin improved slightly by 3.50% YoY to 46.4%. Overall, financial performance shows mixed results with growth in revenue but significant declines in profitability.
Analysts are mixed on the stock. Jefferies downgraded the stock to Hold with a price target of $13.80, citing the acquisition. Oppenheimer upgraded the stock to Outperform with a $14 target, highlighting operational improvements and reimbursement tailwinds. Truist initiated coverage with a Hold rating and a $10.50 target, citing balanced risk/reward. The consensus reflects limited upside due to the acquisition price acting as a cap.
